Carlsbad, CA, United States of America

Andrew A Rodriguez

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Ionis Pharmaceuticals, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew A Rodriguez. Retrieved from https://idiyas.com/inventor/andrew-a-rodriguez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Andrew A. Rodriguez and Oligomeric Compound Synthesis.

Introduction

Andrew A. Rodriguez is an inventor based in Carlsbad, California. His patent work includes a method for synthesizing oligomeric compounds with phosphorothioate diester and phosphodiester linkages.

Latest Patents

Rodriguez is associated with 1 patent: “Synthesis of Oligomeric Compounds Comprising Phosphorothioate Diester and Phosphodiester Linkages.” The patent concerns the synthesis of oligomeric compounds containing these two types of linkages.

Career Highlights

Rodriguez is associated with Ionis Pharmaceuticals, Inc., a company focused on medicines based on antisense technology. His listed patent reflects work in the chemical synthesis of oligomeric compounds.

Collaborations

Among Rodriguez’s listed coworkers are Andrew K. McPherson and Daniel C. Capaldi. Their shared association points to a collaborative research environment connected with the patent.

Conclusion

Andrew A. Rodriguez’s patent record highlights his contribution to oligomeric compound synthesis and his association with Ionis Pharmaceuticals, Inc.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…